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ABSTRACT 
 
The effect of pre-existent hepatic NO synthesis on liver injury induced by lipopolysaccharide was 
studied in animals carrying a nitric oxide synthase-2 (NOS-2) transgene under the control of the 
phosphoenolpyruvate carboxykinase (PEPCK) promoter. These animals expressed NOS-2 in liver 
cells under fasting conditions. Lipopolysaccharide-induced liver injury in D-galactosamine-
conditioned mice, which enhanced notably the effect of the endotoxin on the liver, was impaired in 
animals expressing NOS-2. This protection against inflammatory liver damage was dependent on 
NO synthesis and was caused by an inhibition of nuclear factor κB (NF-κB) activity and an 
impairment of the synthesis of the proinflammatory cytokines tumor necrosis factor α and 
interleukin 1β. These data indicate that intrahepatic synthesis of NO protects liver by inhibiting the 
release of cascades of proinflammatory mediators and suggest a beneficial role for local delivery of 
NO in the control of liver injury.  
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n the course of sepsis, various cell types in the infected organism contribute to the release of 
cytokines [among them tumor necrosis factor α (TNF-α), interleukin 1β (IL-1β), and 
interferon γ (IFN-γ)] and chemokines, which recruit and activate additional cells of the 
immune system. These proinflammatory mediators promote the synthesis of odd molecules that 
participate in host defense, such as reactive-oxygen species, NO, and bioactive lipids (mainly 
prostaglandins, leukotrienes, and thromboxanes) (1–3). Current views about the pharmacological 
control of inflammatory onset have focused on the neutralization or inhibition of release of 
proinflammatory cytokines, as well as on the regulation of NO synthesis, which exerts an 
important pathophysiological action that induces refractory hypotension and severe damage in 
the renal and cardiovascular systems (4–9). 
 
I 
The response of liver to pro-inflammatory stimuli has been well established and, in addition to 
specialized cells (e.g., Kupffer cells), hepatocytes respond to most of these factors (10–14). 
Moreover, the liver is an important contributor to the synthesis of systemic mediators of the 
inflammatory cascade during sepsis, such as acute-phase proteins and pro-inflammatory 
cytokines (15, 16). One key component in the triggering of the inflammatory response is the 
activation of nuclear factor κB (NF-κB), a transcription factor that integrates the signaling 
elicited by various cell stresses and is required for the expression of most genes involved in host 
defense, among them the NOS-2 gene (4, 17–19). Indeed, the important role played by NF-κB 
activation in liver inflammation has been confirmed in animals carrying a degradation-resistant 
IκBα transgene under the control of a liver-specific promoter (20) and in cultured hepatocytes 
transduced with adenovirus carrying an IκBα gene that impairs NOS-2 expression (21). 
 
In liver cells, expression of NOS-2 leads to the synthesis of large amounts of NO, and genetic 
and pharmacological data suggest that this molecule exerts a dual role in the course of 
inflammation: exogenous addition of NO impairs the release of inflammatory mediators (22–25) 
and protects against apoptotic death by inhibiting various caspases via nitrosylation of key 
cysteine residues (26–28). Synthesis of NO after expression of NOS-2 is responsible for an 
important part of the damage occurring during sepsis (29–31). Moreover, the exacerbated 
inflammatory responses in animals resuscitated after hemorrhagic shock, which promotes severe 
damage in liver and lungs, were markedly attenuated in animals lacking NOS-2 or treated with 
NOS-2 inhibitors, due to less NF-κB activation and synthesis of proinflammatory mediators (32). 
However, liver injury in the course of mild endotoxemia even increased when NOS-2 activity 
was inhibited (33). In addition to these effects, NO has been identified as a molecule required for 
liver regeneration after partial hepatectomy, as deduced by the impairment of hepatocyte growth 
in animals with inhibited NOS or lacking the NOS-2 gene (11, 34). 
 
Keeping in mind these previous data, we developed an experimental animal model to investigate 
the potential contribution of NO to the modulation of inflammatory liver injury, in which NO 
was endogenously produced in the hepatocytes by expression of an NOS-2 transgene under the 
control of the liver-specific PEPCK promoter. These animals expressed NOS-2 after fasting, in a 
process that was independent from proinflammatory stimulation. Moreover, the PEPCK 
promoter was activated in the postnatal period, avoiding interference in the course of animal 
development. Using this approach, we have analyzed the pathophysiological effect of sustained 
expression of NOS-2 in hepatocytes during fasting, as well as the modulation exerted by this 
local synthesis of NO on the progression of several models of inflammatory liver injury, taking 
advantage of the enhancement of liver toxicity induced by D-galactosamine (D-GalN) 
administration (35, 36). Our data show that preexistent synthesis of NO in the hepatocyte exerts 
an important protection against lipopolysaccharide (LPS)-dependent injury in D-GalN 
preconditioned mice. 
 
MATERIAL AND METHODS 
 
Chemicals 
 
LPS (from Salmonella enterica serovar Typhimurium), L-N(6)-(1-iminoethyl)lysine (L-NIL), 
TNF-α, and D-GalN were obtained from Sigma (St. Louis, Mo.). N-(3-Aminomethylbenzyl)acetamidine, 
1400W, was a gift from R. Knowles. Antibodies were from Santa Cruz Laboratories (Santa Cruz, 
Calif.) and PharMingen (Heidelberg, Germany). Terminal deoxynucleotidyltransferase-mediated 
dUTP-fluorescein nick-end-labeling (TUNEL) reagents were from Roche (Mannheim, 
Germany). Cytokine assay Biotrak kits, oligonucleotides, and restriction enzymes were from 
Amersham (Bucks, United Kingdom). Electrophoresis equipment and reagents were from Bio-Rad 
(Hercules, Calif.). 
 
Construction of the pPEPCK/NOS-2 gene and generation of transgenic animals 
 
The chimeric gene contained the XbaI-BglII fragment of the rat PEPCK promoter (nucleotides -
450 to +73) linked to the initial 5’ sequence of the human insulin gene in which the transcription 
start site was deleted (BglI-NcoI fragment) (37). To this sequence, the full coding sequences of 
the murine NOS-2 cDNA (3.93 kb) and the 3’ end of the insulin gene (NcoI-HindIII fragment) 
were linked and cloned into a pTZ18R (USB) plasmid, following the strategy described 
previously (37, 38). A 6.2 kb KpnI-HindIII fragment containing the chimeric gene (Fig. 1A) was 
microinjected into fertilized eggs from strain C57Bl6/SJL mice as previously described (37). The 
presence of the transgene was determined in 3-week-old mice by Southern blotting of tail DNA 
that had been digested with EcoRI and HindIII, leading to the excision of a 2.9 kb fragment of 
the transgene (Fig. 1B). Blots were hybridized with the 2.8 kb EcoRI-SSpI fragment 
corresponding to nucleotides +1124 to +3934 of the murine NOS-2 cDNA. The probe was 
radiolabeled with [α-32P]dCTP (3,000 Ci/mmol) by random oligopriming (Amersham). Wild-
type (Wt) and transgenic (Tg) mice were fed ad libitum with a standard diet (Panlab, Barcelona, 
Spain) and kept under a light-dark cycle of alternating 12 h periods (lights on at 8 a.m.). 
Starvation was initiated at 10 a.m. and experiments were started the next day between 8 a.m. and 
10 a.m. 
 
Administration of 1400W, L-NIL, D-GalN, LPS, and TNF-α was done intraperitoneally (i.p.). 
Animals were cared for in agreement with the institutional animal care instructions. Sera were 
obtained by cardiac puncture or through the tail vein. 
 
Measurement of metabolites 
 
Livers were quickly removed and frozen in liquid N2. Lipid peroxidation was quantified by 
measuring malondialdehyde (MDA) products, using the thiobarbituric acid assay (39). GSH and 
GSSG were measured as previously described (40). The amount of 8-OHdG was determined by 
HPLC after isolation and hydrolysis of DNA (41). Serum nitrite plus nitrate was measured using 
a chemiluminescence method, following the recommendations of the manufacturer (NO 
analyzer; Sievers, Boulder, Colo.).  
 
Preparation of cytosolic and nuclear protein extracts 
 
Samples of liver tissue (100–200 mg) were homogenized in 4 volumes of ice-cold buffer A (10 
mM HEPES [pH 7.9], 1 mM EDTA, 1 mM EGTA, 10 mM KCl, 1 mM dithiothreitol, 0.5 mM 
PMSF, 2 µg/ml tosyl-lysyl-chloromethane, 40 µg/ml aprotinin, 4 µg/ml leupeptin, 5 mM NaF, 1 
mM NaVO4, 10 mM Na2MoO4, and 0.5% [vol:vol] Nonidet P-40). After centrifugation at 8,000 
× g for 15 min, the supernatants were stored at –80ºC (soluble extracts), and the pellets were 
resuspended in 200 µl of buffer A supplemented with 20% (vol:vol) glycerol and 0.4 M KCl and 
vortexed for 30 min at 4ºC. The nuclear suspension was centrifuged in an Eppendorf centrifuge, 
and the supernatant was stored at –80ºC (nuclear extract). 
 
Measurement of enzyme activities 
 
The activities of the hepatic markers alanine aminotransferase (ALT), aspartate aminotransferase 
(AST), and γ-glutamyl transferase (γ-GT) were measured at 30ºC, using commercial kits for 
diagnosis. Superoxide dismutase (SOD) was measured by the production of superoxide during the 
conversion of xanthine to uric acid by xanthine oxidase and inhibition of cytochrome c reduction 
(42). Catalase was measured after the decomposition of H2O2 at 240 nm. Glutathione peroxidase 
(GPX) was measured by recording the oxidation of GSH by H2O2. The activity of caspase 3/7 was 
measured using as substrate N-acetyl-DEVD-7-amino-4-methylcoumarin and in the presence of 1 
mM dithiothreitol, by following the instructions of the supplier (PharMingen, Heidelberg, 
Germany). The corresponding peptide aldehyde was used to inhibit the caspase activity in vitro and 
to ensure the specificity of the reaction. The linearity of the caspase assays was determined over a 
30-min reaction period. 
 
Analysis of gene expression by Northern blot 
 
Total RNA was extracted from 50 mg of liver tissue by the guanidinium thiocyanate method (18). 
After electrophoresis in a 0.9% agarose gel containing 2% formaldehyde, the RNA was transferred 
to a Nytran membrane (NY 13-N; Schleicher & Schuell, Dassel, Germany), and the level of IκBα 
mRNA was determined using the full cDNA as a probe, after labeling with the Rediprime kit 
(Amersham). The membranes were exposed to Hyperfilm X-ray films (Amersham), and the 
intensity of the bands was measured by laser densitometry (Molecular Dynamics). The lane charge 
was normalized by hybridization with a ribosomal 18S probe. 
 
Western blot analysis 
 
The relative amounts of NOS-2, IκBα, and procaspase 3 were determined in soluble extracts. 
The levels of p65 were determined in nuclear extracts. Equal amounts of protein were size-
fractionated by SDS-10% PAGE, transferred to a PVDF membrane (Amersham), and, after 
blocking with 5% nonfat dry milk, incubated with the corresponding antibodies (1:1000) from 
Santa Cruz Laboratories. The blot was revealed after incubation with horseradish peroxidase-
conjugated IgG (1:2000) and after following the ECL protocol (Amersham), as recommended by 
the manufacturer. Different exposition times were performed for each blot to ensure the linearity 
of the band intensities. Densitometric analysis of the bands was carried out using a laser 
densitometer (Molecular Dynamics, Sunnyvale Calif.). 
 
Electrophoretic mobility shift assays (EMSAs) 
 
The oligonucleotide corresponding to the proximal κB motif of the murine iNOS promoter (43) 5'-
CCAACTGGGGACTCTCCCTTTGGGAACA-3' (50 ng) was annealed with the complementary 
sequence and end-labeled with Klenow enzyme in the presence of 50 µCi of [α-32P]dCTP and the 
other unlabeled dNTP in a final volume of 50 µl. The oligonucleotide was precipitated with ethanol 
and extracted with phenol/chloroform (44). Binding assays of nuclear extracts were carried out with 
5 × 104 dpm of the DNA probe as follows: nuclear protein extract (5 µg) was incubated for 30 min 
at 4oC with the DNA and 1-µg/ml poly(dI⋅dC), 5% glycerol, 1 mM EDTA, 100 mM KCl, 5 mM 
MgCl2, 1 mM dithiothreitol, and 10 mM Tris-HCl (pH 7.8), in a final volume of 20 µl. Samples 
were applied to a 6% polyacrylamide gel which had been previously electrophoresed for 30 min at 
100 V. Gels were run at 0.8 V/cm2 in 45 mM Tris-borate, followed by transfer to 3MM Whatman 
filter paper, drying under vacuum at 80ºC, and quantification of the band intensities in an 
autoradiograph (Fuji Bas 1000). Specificity of the protein-DNA interaction was ensured by serial 
dilutions of the binding assay with an excess of unlabeled probe. Supershift assays were carried 
out after incubation of the nuclear extracts at 4ºC for 30 min with 2 µg of the indicated Abs.  
 
Cytokine assay 
 
The serum levels of TNF-α and IL-1β were measured per duplicate sample, using commercial kits 
(Biotrak; Amersham). 
 
Cytochemistry and TUNEL assays 
 
Liver sections were fixed on 2% paraformaldehyde in phosphate buffer and embedded into paraffin. 
After deparaffinization, sections of 8 µm in thickness were stained with hematoxylin and eosin, or 
they were treated with the reagents of the TUNEL kit (Roche) to evaluate apoptosis. 
 
DNA extraction and analysis 
 
Internucleosomal DNA fragmentation was analyzed by agarose gel electrophoresis (45). Samples 
of liver (200 mg each) were Dounce homogenized with 1.5 ml of 10 mM EDTA, 0.25% Triton X-
100, and 20 mM Tris-HCl (pH 8.0) (15 min at 4ºC). The DNA was precipitated with 70% ethanol 
plus 2 mM MgSO4 and treated for 4 h at 55ºC with 0.5 mg/ml of proteinase K. After two 
extractions with phenol/chloroform, the DNA was analyzed in a 2% agarose gel and stained with 
0.5 µg/ml of ethidium bromide. 
 
Statistical analysis 
 
The data described are the means + SD of the indicated number of experiments. Statistical 
significance was estimated with Student's t-test for unpaired observations. A P value of less than 
0.05 was considered significant. In studies using Western blot analysis, linear correlations between 
increasing amounts of protein and signal intensity were observed. 
 
RESULTS 
 
Expression of the NOS-2 transgene under fasting conditions 
 
The presence of the NOS-2 transgene was determined by Southern blotting of tail DNA (Fig. 1B), 
the expression of this enzyme was assessed after starvation for both 24 and 48 h, and analysis of 
NOS-2 in liver cells was accomplished by Western blotting. As Figure 1C shows, the protein was 
undetectable in fed animals, but a band of the expected size of NOS-2 was observed in animals 
starved for 24 h; however, prolonged starvation of up to 48 h did not result in higher levels of NOS-
2. To ensure that this enzyme was active in the animal, the serum levels of NO2− plus NO3− (NOx), 
as end products of NO biosynthesis, were measured in fed and starved conditions (Fig. 1D). The 
maximal levels of NOx were detected at 24 h and were inhibited after administration of the NOS-2 
inhibitors 1400W (Fig. 1D) and L-NIL (not shown). Moreover, in vitro measurement of NOS-2 
activity in liver extracts by the conversion of arginine into citrulline and inhibition by 1400W 
confirmed the expression of a functional enzyme in Tg animals under fasting conditions (data not 
shown). The presence of NOS-2 in other tissues of mice that had fasted was determined by Western 
blot, and only moderate expression in kidney cells was observed [note that the blot was overexposed 
for liver (Fig. 1E)]. 
 
Because the sustained synthesis of NO in starved animals might influence liver physiology, we 
investigated the levels of metabolites sensitive to NO as well as those of enzymes involved in 
oxidative stress. As Figure 2 shows, the levels of GSH decreased notably in both Wt and Tg animals 
under fasting conditions, and this effect was paralleled by an increase in GSSG concentration (3.8-
fold with respect to the Wt group at 48 h). The accumulation of 8-OHdG increased significantly by 
24 h of starvation in Tg animals with respect to the Wt (twofold), and an increase of MDA (2.1-
fold) was evidenced after 48 h. Regarding enzymes involved in oxidative stress, moderate but 
significant changes were observed in the activities of catalase at 48 h of starvation (57% increase) 
and SOD at 24 h (55%). The most significant change was observed in GPX, which increased 3.4-
fold in starved Tg animals when compared with the Wt (Fig. 2). 
 
Protection by endogenous NO against LPS/D-GalN toxicity 
 
To further investigate in Tg animals the role of fasting-dependent NO synthesis on liver function, 
we analyzed two models of lethal endotoxic injury: i.p. injection of a high dose of LPS (40 mg/kg), 
and i.p. administration of a low dose of LPS (10 µg/kg) or TNF-α (20 µg/kg) in combination with 
D-GalN (800 mg/kg) and L-NIL (5 mg/kg), an inhibitor of NOS-2 activity. As Table 1 shows, the 
survival rates with high doses of LPS did not significantly differ between Wt and Tg animals, 
regardless of their nutritional status. However, in D-GalN-conditioned mice, a protective effect (ca. 
75%) was observed in Tg animals expressing NOS-2, after challenge with a low dose of LPS. When 
animals were treated with TNF-α and D-GalN, significant protection was still observed in the Tg 
group that had fasted, although this protection was less efficient than that after LPS/D-GalN 
administration (67% of survival). It is interesting that when NOS-2 activity was inhibited with L-
NIL, the protective effect of endogenous NO was lost. These results suggest that impairment of 
proinflammatory cytokine synthesis by NO in liver is a likely mechanism mediating animal 
survival, as observed in other models of acute endotoxic liver injury (46, 47). To analyze the 
protection exerted by NO synthesis on LPS/D-GalN-dependent toxicity, the levels of the 
proinflammatory cytokines TNF-α and IL-β were determined at 4 h after i.p. challenge. As Figure 3 
shows, 3.6- and 6.5-fold reductions of TNF-α and IL-1β levels, respectively, were observed in 
starved Tg animals, an effect that was lost after treatment with the NOS-2 inhibitor L-NIL. This 
reduced inflammatory response was absent in fed animals. In parallel to determination of the serum 
levels of proinflammatory cytokines, the activities of hepatic lesion markers γ-GT, ALT, and AST 
were determined to evaluate the degree of hepatic injury. As Figure 4 shows, a remarkable reduction 
in the serum levels of ALT (76%) and AST (65%) was observed, in agreement with the decreased 
levels of proinflammatory cytokines. However, the release of γ-GT activity was proportionally 
higher than that of transaminases (55% decrease).  
 
Impairment of NF-κB activity in Tg animals expressing NOS-2 
 
One of the potential mechanisms of protection against LPS/D-GalN injury is the inhibition of NF-
κB activation due to the endogenous synthesis of NO. To investigate this possibility, liver extracts 
were prepared, and the activity of NF-κB in the nuclear protein fraction was evaluated by EMSA. 
As Figure 5A shows, an important decrease of NF-κB activity was observed in starved Tg animals 
treated with LPS/D-GalN. Analysis of the retained bands by supershift assays showed a dominant 
composition of p50-p65 complexes in the upper band and p50 homodimers in the lower band, 
respectively. The attenuated NF-κB activity in starved Tg mice was accompanied by the presence of 
lower levels of p65 in the nuclear extracts and higher levels of IκBα, an inhibitory protein of NF-κB 
that retains the complex in the cytosol,  in the corresponding soluble fraction (18, 48). This 
decreased NF-κB activity was accompanied by reduced levels of IκBα mRNA, an early and 
sensitive NF-κB-regulated gene (Fig. 5B), reflecting an impaired inflammatory status.  
 
Part of the cytotoxic effects due to LPS/D-GalN administration have been attributed to induction of 
liver apoptosis. To better evaluate the protection against apoptosis exerted by endogenous NO, liver 
extracts were prepared, and the levels of procaspase 3, the activity of caspase 3, and the 
nucleosomal fragmentation of DNA were determined. As Figure 6A shows, the levels of procaspase 
3 were maintained in Tg animals that had fasted (up to 7 h after LPS/D-GalN challenge), whereas a 
significant decrease in procaspase 3 was observed in the corresponding Wt animals. The decrease in 
procaspase 3 was paralleled by the appearance of caspase-3 activity. This activity was measured in 
the presence of 1 mM dithiothreitol, which abrogates any possible inhibitory nitrosylation of the 
enzyme (49) (Fig. 6B), and by the occurrence of internucleosomal degradation of DNA when 
examined in agarose gels (Fig. 6C). Inhibition of NOS-2 activity with L-NIL suppressed the 
protective effects of NO synthesis in Tg animals. Moreover, TUNEL assays of liver sections 
obtained 7 h after LPS/D-GalN challenge showed an intense nuclear staining in starved Wt animals, 
together with a marked alteration in the tissue structure (deduced from hematoxylin and eosin 
staining), reflecting a certain degree of necrosis (Fig. 7). However, this response was absent in Tg 
animals that exhibited a normal tissue morphology, and, occasionally, the cells surrounding the 
centrilobular vein exhibited an increased fluorescence in the cytoplasm but not in the nucleus, 
suggesting certain apoptotic damage. It is interesting that treatment of animals with L-NIL 
suppressed the protective effect exerted by the endogenous synthesis of NO.  
 
DISCUSSION 
 
A study of the effects of NO in a particular tissue using an exogenous source of this molecule 
encompasses many undesirable side effects due to the yet unresolved difficulty of selective 
delivery in the organ, at least at NO concentrations similar to those released after NOS-2 
expression. To overcome this problem in the liver, we engineered mice carrying a fasting-
inducible NOS-2 transgene, which allows the synthesis of NO independently of inflammatory 
stimulation. Phenotypically, the expression of NOS-2 after the animals had fasted promoted a 
moderate change in the parameters related to oxidative stress, but this NO synthesis did not 
affect significantly the life-span, or it involved other systemic alterations of the normal behavior 
of the Tg animals with respect to the corresponding Wts. We analyzed other organs to determine 
the expression of the transgene and, except for minor expression in kidney tissue, it was not 
expressed in other organs including pancreas. These results suggest that moderate generation of 
NO at the hepatic level has no noticeable deleterious effects on liver. Indeed, it has been found 
that NOS-2 is expressed and functional in the trophoblasts after midterm pregnancy, and this NO 
seems not to affect other organs (50). However, in Tg animals carrying NOS-2 under the control 
of the insulin promoter, pancreatic cells expressed this enzyme, and the synthesis of NO 
provoked β-cell degeneration and the development of insulin-dependent diabetes (51). 
 
Regarding our model, the data showed that administration of a high dose of LPS was lethal for 
both Wt and Tg animals, independently of their nutritional status. This lethality might be due to 
the insult exerted by LPS over other organs in addition to liver, likely including the renal and 
vascular systems. However, in D-GalN-conditioned mice, intrahepatic synthesis of NO protected 
against the lethal injury elicited by low doses of LPS, as deduced from the use of NOS-2 
inhibitors, that suppressed the protection exerted by endogenous synthesis of NO in Tg animals 
and by the maintenance of liver function and structure under these conditions. Sensitization of 
animals with D-GalN enhanced the liver response to inflammatory factors, which allowed 
working with much lower concentrations of these molecules (36). Indeed, using high doses of 
LPS, Rouquet et al. (52) observed lethality in a model of inhibition of caspase activity with 
YVAD.CMK; however, complete protection by this inhibitor was obtained in the LPS/D-GalN 
model, suggesting an important contribution of liver apoptosis to the lethality induced by LPS in 
D-GalN conditioned mice (26–28, 45, 53). In this regard, it is worthwhile to mention that, in 
transgenic animals overexpressing endothelial NOS, the enhanced NO synthesis protected the 
animals from LPS-induced septic shock. In this case, the mechanism by which endothelial NOS 
prevented LPS lethality involved i) attenuation of the expression of NOS-2, ii) impairment of 
vascular reactivity to NO, and iii) inhibition of the expression of vascular cell adhesion 
molecule-1 (VCAM-1) and ICAM-1, concomitant with a reduction in the infiltration of 
leukocytes in various organs (54). 
 
Analysis of the mechanisms mediating the protection exerted by hepatic NO synthesis included 
that of the inhibition of NF-κB activation, which was evidenced soon after LPS challenge and, 
therefore, was an impairment of the release of TNF-α, IL-1β, and presumably of other 
proinflammatory cytokines dependent on NF-κB activity (2, 17). The contribution of 
proinflammatory cytokines to lethality in the LPS/D-GalN model, in particular TNF-α, has been 
well established since survival to LPS was observed in mice lacking TNF-α or the p55 receptor 
of TNF-α (47). Also, pretreatment of animals with a moderate nonlethal dose of LPS reduced the 
lethality of a further administration of LPS/D-GalN, including a reduction in the synthesis of 
TNF-α (55). Opposite to the protective effect by preexistent NO, the NO produced as a result of 
inflammatory expression of NOS-2 plays an important role in the pathogenesis of septic shock 
(7, 9). Indeed, induction of sepsis in mice deficient in NOS-2 resulted in a lower mortality than 
in the Wt counterparts, with a better evolution in the pharmacological management of 
hypotension with norepinephrine (56). 
 
The impairment of NF-κB activity by intrahepatic NO might be due to an up-regulation of IκBα 
levels, a fact observed systematically in Tg animals that had fasted; to an inhibition of IκB 
phosphorylation (17), due to the inhibitory effect of NO on IκB kinase-2 activity (unpublished 
data); and to an inappropriate targeting of IκB due to the inhibition of the proteasome activity by 
NO (57). Consistent with these suggestions are the data obtained using a "tet-off" transgenic 
system to express a degradation-resistant mutant of IκBα (20). These mutants demonstrate a 
regulated disruption of NF-κB activity in postnatal liver tissue, but this disruption has no effect 
on the normal physiology of the organ; however, it severely impairs the ability to clear infection 
from the liver, indicating that NF-κB acts as an integrator of innate immunity in this organ. In 
addition to these effects of NO on IκB targeting, it has been described that pretreatment of 
cultured hepatocytes with NO donors protects against TNF-α-dependent hepatotoxicity by up-
regulating heat shock protein 70 (hsp70) expression (53). Moreover, this increase of hsp70 
appears to be dependent on an enhancement of GSSG concentration, a situation observed in 
fasted Tg animals. 
 
An aspect partially explored in this work was the contribution of NO-dependent inhibition of 
procaspase activation and caspase activity to protection against liver inflammatory injury. NO 
inhibits the activities of liver caspases 3 and 8 through an S-nitrosylation mechanism, and they 
appear to be the most relevant executioner caspases in this organ (49, 58). The efficiency of this 
protective mechanism was confirmed using a model of adenovirus-mediated gene transfer of 
NOS-2 that abrogated the apoptosis dependent on TNF-α and actinomycin D (27). Moreover, in 
a model of concanavalin A-induced hepatitis, administration of chemical donors of NO improved 
survival through a mechanism that inhibited caspase-dependent processing of the Th1 response 
that mediates the coordinate apoptotic action of the cytokines released by CD4+ T cells and T-
helper cells. This caused Fas-dependent hepatocyte death (59). In our model, the amount of 
procaspase 3 was well conserved in Tg animals that had fasted after LPS/D-GalN challenge, and 
activation of caspase 3 (total activity because it was measured in the presence of dithiothreitol) 
was significantly lower than in the Wt group. In agreement with these results, minimal DNA 
laddering and TUNEL staining were observed in Tg animals when compared with that of their 
Wt counterparts. 
 
Taken together these data suggest that the availability of a molecule delivering NO in the 
hepatocyte as result of hepatic metabolism might constitute a useful drug for the therapeutic 
management of various liver diseases. 
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Table 1 
 
Fed Starved (24 h) i.p.challenge 
L-NIL       D-GalN 
(mg/kg)      (mg/kg)   
LPS 
(µg/kg) 
TNF-α 
(µg/kg) 
 
Wt 
(survival/group) 
 
Tg 
(survival/group) 
 
Wt 
(survival/group) 
 
Tg 
(survival/group) 
        -                -            40,000        - 2/10                 1/10 1/10                  0/10 
        -              800               -            - 5/5                   5/5 6/6                    7/7 
        -                -                10           - 4/4                   4/4 5/5                    5/5 
        -              800              10          - 2/8                   2/8 0/12                  9/12 
       5              800              10           - 2/5                   1/5 2/7                    1/7 
        -                -                 -            20 5/5                   4/5 4/5                    5/5 
        -              800              -            20  1/10                 0/10 2/12                  8/12 
       5              800              -            20 1/5                   0/5 0/6                    1/6 
    
Table 1. Effect of LPS, TNF-α, D-GalN, and the NOS-2 inhibitor L-NIL on animal survival. Animals aged 12–16 
wk were i.p. injected 1 ml of a mixture of the indicated stimuli in PBS. L-NIL was administered 30 min prior to pro-
inflammatory treatment, and 8 h later. Starvation was carried out prior to challenge, and afterwards the animals had free 
access for food. The survival rates were determined 48 h after challenge. 
Fig. 1 
 
 
Figure 1. Analysis of the expression of the pPEPCK/NOS-2 transgene. The 6.2-kb fragment containing the NOS-2 
gene under the transcriptional control of the PEPCK promoter was microinjected into fertilized eggs (A). The presence of 
the chimeric transgene was determined by Southern blotting tail DNA (B). The expression of NOS-2 in Tg animals was 
determined at 0, 24, and 48 h of fasting by Western blotting liver extracts (C). In vivo expression and activity of NOS-2 
was evaluated by measuring the accumulation of nitrate and nitrite in the serum by chemiluminiscence. Inhibition of 
NOS-2 activity in vivo with 1400W (i.p. administration at 20 mg/kg) was carried out twice per day (D). Analysis of NOS-
2 levels in different tissues was carried out by Western blot (20 µg of protein) after 24 h of fasting. The blot was over-
exposed for the liver sample (E). Results show the blots of two animals per condition (B, C) the serum levels of NOx 
from four animals of each condition (mean + SD; D), and a representative blot (E). *P < 0.5, **P < 0.01 with respect to 
Wt animals under identical nutritional status. 
Fig. 2 
 
Figure 2. Metabolite concentrations and enzyme activities related to oxidative stress in Tg animals. Livers were 
removed at the indicated times and the concentrations of GSH, GSSG, MDA, and 8-OHdG were determined. The 
concentrations of these metabolites (mean + SD) in Wt animals at 0 h were 1.73 + 0.52, 0.42 + 0.19, and 0.29 + 0.19 
µmol/g of protein for GSH, GSSG, and MDA, and 2.6 + 0.85 residues of 8-OHdG per 105 bases of dG (n=7), respectively. 
The activity of catalase, GPX, and SOD was determined. The activities in Wt animals at 0 h were 40.2 + 2.1, 9.98 + 3.5, 
and 16,000 + 427 U/g of protein (n=6), respectively. Values were expressed in percentage, corresponding to the 100% 
value to Wt animals at 0 h. *P < 0.5, **P < 0.01 with respect to Wt animals under identical nutritional conditions. 
Fig. 3 
 
Figure 3. Impairment of the synthesis of pro-inflammatory cytokines in Tg animals expressing NOS-2. Fed and 
starved (24 h) Wt and Tg animals were challenged with i.p. injection of 1 ml of LPS (10 µg/kg) and D-GalN (800 mg/kg) 
dissolved in saline. L-NIL (5 mg/kg) was administered 30 min prior to challenge. The serum levels of TNF-α and IL-1β 
were determined after 4 h of challenge. Results show the mean + SD of three experiments (n=4). *P < 0.001 with respect 
to Wt animals under identical nutritional conditions. 
Fig. 4 
         
Figure 4. Protection by NO against LPS/D-GalN-induced liver injury. Animals were treated as indicated in Figure 3, 
and the activity of aspartate and alanine aminotransferases and γ-glutamyltransferase (AST, ALT, and γGT, respectively) 
was measured in serum 5 h after challenge. *P < 0.005 with respect to Wt animals under identical nutritional conditions. 
Fig. 5 
    
Figure 5. Inhibition of NF-κB activity in Tg animals expressing NOS-2. Fasted animals were treated with  
LPS/D-GalN, and at the indicated times the livers were removed and processed to prepare soluble and nuclear protein 
extracts. The binding of nuclear proteins to the proximal κB motif of the murine NOS-2 promoter was analyzed by 
EMSA. Supershift assays were carried out with the Wt samples at 30 min. The levels of p65 (nuclear) and IκBα 
(cytosolic) were determined by Western blot (left panel). The levels of IκBα mRNA were determined by Northern blot in 
liver samples obtained at the indicated times (right panel). The amount of 18S ribosomal RNA was used to normalize the 
lane charge of RNA. Results show a representative experiment out of four. 
Fig. 6 
    
Figure 6. Protection by endogenous NO against LPS/D-GalN-induced apoptosis. Animals were treated as described in 
Figure 3. Livers were removed at the indicated times, and tissue extracts were prepared. Samples of soluble fraction were 
analyzed by Western blot by using an anti-caspase-3 Ab (A). The caspase activity was assayed at 5 h after LPS/D-GalN 
challenge by using the methylcoumarin conjugate of DEVD (caspase 3) as substrate. As a control of the specificity of the 
reaction, the basal activity corresponding to samples incubated with the corresponding peptide aldehydes was subtracted 
(B). The DNA obtained from animals treated for 7 h with LPS/D-GalN was analyzed by electrophoresis in agarose gels 
(C). Results show a representative experiment out of three (A, C), and the mean + SD of four experiments (B). *P < 0.005 
with respect to the corresponding Wt group. 
 
Fig. 7 
    
Figure 7. TUNEL assay and cytochemistry of liver sections from fasted Wt and Tg animals. Livers from control and 
animals treated 7 h with LPS/D-GalN animals and with or without L-NIL (5 mg/kg) were obtained and fixed in 2% 
paraformaldehyde in phosphate buffer. Sections of 8 µm were used for TUNEL following the instructions of the supplier 
(Roche); original magnification, ×630. Staining with hematoxylin and eosin was carried out with samples of challenged 
animals at 7 h; original magnification, ×200. 
 
